An industry analysis by Grant Moss of Adapt IP Ventures and reported in IAM online magazine, suggests that IP valuation within the medical device industry appear to be declining. The analysis based on a study of identified licensing transactions and royalty rates, suggests that increasing IP values will face continuing challenges in the coming year.